Skip to content
All Podcasts – Lifestyle
Author:
Castle Biosciences, Inc.
Castle Biosciences Earns 2026 USA TODAY Top Workplaces Award for Fifth Consecutive Year
April 10, 2026
Castle Biosciences’ DecisionDx®-Melanoma Test Significantly Improves Risk Prediction Within AJCC Stages to Support Personalized, Risk-Aligned Management of Cutaneous Melanoma, Data to Be Presented at AAD 2026
March 27, 2026
DecisionDx®-Melanoma’s i31-SLNB: Report from the Largest Prospective Multicenter Study to Date Confirms 2.6% Nodal Positivity in Patients Predicted to Have Less Than 5% Risk
March 9, 2026
Castle Biosciences Announces Grand Opening of New Corporate Headquarters in Friendswood, Texas
March 5, 2026
←
Previous Page
1
2
3